+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

At-Home Drug of Abuse - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

  • ID: 4655427
  • Report
  • Region: Global
  • 168 pages
  • Prescient & Strategic Intelligence Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Confirm BioSciences
  • Home Health (U.K.) Ltd.
  • Phamatech Inc.
  • Psychemedics Corporation
  • Quest Products Inc.
  • MORE
Global at-home DOA testing market is projected to attain a size of $831.9 million by 2023, the market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.

On the basis of various types of products, the at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers. The market for rapid DOA test kits is expected to witness faster growth during the forecast period, attributed to the increasing adoption of various types of rapid DOA test kits, including test cups and dip cards. Also, these test kits are much cheaper as compared to breath analyzers.

Further, the rapid DOA test kits are bifurcated into test cups, test strips, test dip cards, and other types of kits. Amongst all these, the DOA test cups dominated the global rapid DOA test kits market in 2017. Extensive use of test cups for at-home urine drug testing is a key factor driving the market for this product category.

Samples used for at-home DOA testing are urine, saliva, hair, and other different types of samples. Of these, the products using urine as a sample are expected to witness the fastest growth in the at-home DOA testing market during the forecast period. DOA detection through urine sample is the easiest and most affordable way of at-home DOA testing. It is, therefore, the most commonly used method to analyze the presence of illegal and prescribed drugs in the body.

During the forecast period, the at-home DOA testing market is forecasted to witness the fastest growth in APAC, at a CAGR of 11.0%. This growth is attributed to the rising consumption of illicit drugs in the region. Also, the region is a large producer and trader of illicit drugs, including opium, heroin, amphetamine-type stimulants (ATS), and methamphetamines.

Besides, the limited availability of data on drug abuse within the region has necessitated the development and implementation of government initiatives on drug testing, which in turn, would contribute to the growth of the market in APAC in the coming years. For instance, a number of United Nations Office on Drugs and Crime (UNODC) programs have improved data collection networks, particularly in East and Southeast Asia. However, populous countries, including India and China, in the APAC region face a significant data gap, which requires government intervention. The increasing governments’ initiatives to control drugs abuse lead the growth of the APAC at-home DOA testing market during the forecast period.

The companies operating in the at-home DOA testing industry are acquiring other firms and establishing their presence in different economies to increase their market share. Abbott Laboratories (Abbott) being a major player in the production of at-home DOA testing products acquired Alere Inc. in 2017, to increase its share in the point-of-care testing diagnostics market. The addition of this business aligns with Abbott's strategy for the growth of company and complements the leadership positions across its other businesses, which include medical devices, nutritional supplements, and pharmaceuticals.

Some of the other key players in the at-home DOA testing industry are UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Express Diagnostics Int’l Inc., Assure Tech (Hangzhou) Co. Ltd., Psychemedics Corporation, Confirm BioSciences, Phamatech Inc., Home Health (U.K.) Ltd., and Quest Products Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Confirm BioSciences
  • Home Health (U.K.) Ltd.
  • Phamatech Inc.
  • Psychemedics Corporation
  • Quest Products Inc.
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Sample
1.3.3 Market Segmentation by Geography
1.3.4 Analysis Period
1.3.5 Market Data Reporting Unit
1.3.5.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary
3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Rapid DOA test kits
4.1.1.1.1 Test cups
4.1.1.1.2 Test dip cards
4.1.1.1.3 Test strips
4.1.1.1.4 Others
4.1.1.2 Breath analyzers
4.1.2 By Sample
4.1.2.1 Urine
4.1.2.2 Saliva
4.1.2.3 Hair
4.1.2.4 Others
4.2 Regulatory Framework
4.2.1 U.S.
4.2.2 Europe
4.3 Market Dynamics
4.3.1 Trends
4.3.1.1 Rising addiction for synthetic cannabinoids, bath salts, and other emerging drugs
4.3.2 Drivers
4.3.2.1 Increased production and trade of illicit drugs worldwide
4.3.2.2 Growing use of illicit drugs amongst teenagers
4.3.2.3 Initiatives by government organizations to reduce the level of drug abuse
4.3.2.4 Impact analysis of drivers on market forecast
4.3.3 Restraints
4.3.3.1 Legalization of illicit drugs
4.3.3.2 Social issues associated with substance use testing
4.3.3.3 Inefficiency of testing products to detect designer drugs
4.3.3.4 Impact analysis of restraints on market forecast
4.3.4 Opportunities
4.3.4.1 Rising awareness about DOA testing in emerging economies
4.3.4.2 Alternative substance addiction from common household products
4.4 Porter's Five Forces Analysis

Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Rapid DOA Test Kits Market by Type
5.2 By Sample
5.3 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 Rapid DOA Test Kits Market by Type
6.2 By Sample
6.3 By Country
6.3.1 U.S. At-Home DOA Testing Market
6.3.1.1 By product
6.3.1.1.1 Rapid DOA test kits market by type
6.3.1.2 By sample
6.3.2 Canada At-Home DOA Testing Market
6.3.2.1 By product
6.3.2.1.1 Rapid DOA test kits market by type
6.3.2.2 By sample

Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 Rapid DOA Test Kits Market by Type
7.2 By Sample
7.3 By Country
7.3.1 U.K. At-Home DOA Testing Market
7.3.1.1 By product
7.3.1.1.1 Rapid DOA test kits market by type
7.3.1.2 By sample
7.3.2 Germany At-Home DOA Testing Market
7.3.2.1 By product
7.3.2.1.1 Rapid DOA test kits market by type
7.3.2.2 By sample
7.3.3 France At-Home DOA Testing Market
7.3.3.1 By product
7.3.3.1.1 Rapid DOA test kits market by type
7.3.3.2 By sample
7.3.4 Italy At-Home DOA Testing Market
7.3.4.1 By product
7.3.4.1.1 Rapid DOA test kits market by type
7.3.4.2 By sample

Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 Rapid DOA Test Kits Market by Type
8.2 By Sample
8.3 By Country
8.3.1 China At-Home DOA Testing Market
8.3.1.1 By product
8.3.1.1.1 Rapid DOA test kits market by type
8.3.1.2 By sample
8.3.2 Japan At-Home DOA Testing Market
8.3.2.1 By product
8.3.2.1.1 Rapid DOA test kits market by type
8.3.2.2 By sample
8.3.3 India At-Home DOA Testing Market
8.3.3.1 By product
8.3.3.1.1 Rapid DOA test kits market by type
8.3.3.2 By sample
8.3.4 Australia At-Home DOA Testing Market
8.3.4.1 By product
8.3.4.1.1 Rapid DOA test kits market by type
8.3.4.2 By sample

Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 Rapid DOA Test Kits Market by Type
9.2 By Sample
9.3 By Country
9.3.1 Brazil At-Home DOA Testing Market
9.3.1.1 By product
9.3.1.1.1 Rapid DOA test kits market by type
9.3.1.2 By sample
9.3.2 Mexico At-Home DOA Testing Market
9.3.2.1 By product
9.3.2.1.1 Rapid DOA test kits market by type
9.3.2.2 By sample

Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 Rapid DOA Test Kits Market by Type
10.2 By Sample
10.3 By Country

Chapter 11. Competitive Landscape
11.1 Product Benchmarking of Key Players
11.2 Global Strategic Developments of Key Players
11.2.1 Product Launches and Approvals
11.2.2 Other Developments

Chapter 12. Company Profiles
12.1 UCP Biosciences Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.2 Orient New Life Medical Co. Ltd.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.3 Express Diagnostics Int'l Inc.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Strategic Growth Plans
12.4 Assure Tech (Hangzhou) Co. Ltd.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.5 Psychemedics Corporation
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.5.4 Strategic Growth Plans
12.6 Confirm BioSciences
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.7 Phamatech Inc.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Home Health (U.K.) Ltd.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Quest Products Inc.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Abbott Laboratories
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.10.4 Strategic Growth Plans

Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports

List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 5 GLOBAL AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 6 GLOBAL RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 7 GLOBAL RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 8 GLOBAL AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 9 GLOBAL AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 10 GLOBAL AT-HOME DOA TESTING MARKET, BY REGION, $M (2013-2017)
TABLE 11 GLOBAL AT-HOME DOA TESTING MARKET, BY REGION, $M (2018-2023)
TABLE 12 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 13 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 14 NORTH AMERICA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 15 NORTH AMERICA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 16 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 17 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 18 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2017)
TABLE 19 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2018-2023)
TABLE 20 U.S. AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 21 U.S. AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 22 U.S. RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 23 U.S. RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 24 U.S. AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 25 U.S. AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 26 CANADA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 27 CANADA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 28 CANADA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 29 CANADA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 30 CANADA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 31 CANADA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 32 EUROPE AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 33 EUROPE AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 34 EUROPE RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 35 EUROPE RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 36 EUROPE AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 37 EUROPE AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 38 EUROPE AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2017)
TABLE 39 EUROPE AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2018-2023)
TABLE 40 U.K. AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 41 U.K. AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 42 U.K. RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 43 U.K. RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 44 U.K. AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 45 U.K. AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 46 GERMANY AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 47 GERMANY AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 48 GERMANY RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 49 GERMANY RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 50 GERMANY AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 51 GERMANY AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 52 FRANCE AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 53 FRANCE AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 54 FRANCE RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 55 FRANCE RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 56 FRANCE AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 57 FRANCE AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 58 ITALY AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 59 ITALY AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 60 ITALY RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 61 ITALY RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 62 ITALY AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 63 ITALY AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 64 APAC AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 65 APAC AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 66 APAC RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 67 APAC RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 68 APAC AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 69 APAC AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 70 APAC AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2017)
TABLE 71 APAC AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2018-2023)
TABLE 72 CHINA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 73 CHINA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 74 CHINA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 75 CHINA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 76 CHINA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 77 CHINA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 78 JAPAN AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 79 JAPAN AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 80 JAPAN RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 81 JAPAN RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 82 JAPAN AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 83 JAPAN AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 84 INDIA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 85 INDIA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 86 INDIA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 87 INDIA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 88 INDIA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 89 INDIA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 90 AUSTRALIA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 91 AUSTRALIA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 92 AUSTRALIA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 93 AUSTRALIA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 94 AUSTRALIA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 95 AUSTRALIA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 96 LATAM AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 97 LATAM AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 98 LATAM RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 99 LATAM RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 100 LATAM AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 101 LATAM AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 102 LATAM AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2017)
TABLE 103 LATAM AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2018-2023)
TABLE 104 BRAZIL AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 105 BRAZIL AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 106 BRAZIL RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 107 BRAZIL RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 108 BRAZIL AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 109 BRAZIL AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 110 MEXICO AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 111 MEXICO AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 112 MEXICO RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 113 MEXICO RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 114 MEXICO AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 115 MEXICO AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 116 MEA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2017)
TABLE 117 MEA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2018-2023)
TABLE 118 MEA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2017)
TABLE 119 MEA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2018-2023)
TABLE 120 MEA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2017)
TABLE 121 MEA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2018-2023)
TABLE 122 MEA AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2017)
TABLE 123 MEA AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2018-2023)
TABLE 124 UCP BIOSCIENCES INC. - AT A GLANCE
TABLE 125 ORIENT NEW LIFE MEDICAL CO. LTD. - AT A GLANCE
TABLE 126 EXPRESS DIAGNOSTICS INT'L INC. - AT A GLANCE
TABLE 127 ASSURE TECH (HANGZHOU) CO. LTD. - AT A GLANCE
TABLE 128 PSYCHEMEDICS CORPORATION - AT A GLANCE
TABLE 129 PSYCHEMEDICS CORPORATION - KEY FINANCIAL SUMMARY
TABLE 130 CONFIRM BIOSCIENCES - AT A GLANCE
TABLE 131 PHAMATECH INC. - AT A GLANCE
TABLE 132 HOME HEALTH (U.K.) LTD. - AT A GLANCE
TABLE 133 QUEST PRODUCTS INC. - AT A GLANCE
TABLE 134 ABBOTT LABORATORIES - AT A GLANCE
TABLE 135 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY

List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL AT-HOME DOA TESTING MARKET SUMMARY
FIG 9 OPINION OF INDUSTRY EXPERTS/KOLS
FIG 10 BARGAINING POWER OF BUYERS
FIG 11 BARGAINING POWER OF SUPPLIERS
FIG 12 INTENSITY OF RIVALRY
FIG 13 THREAT OF NEW ENTRANTS
FIG 14 THREAT OF SUBSTITUTES
FIG 15 GLOBAL AT-HOME DOA TESTING MARKET SNAPSHOT
FIG 16 GLOBAL AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2023)
FIG 17 GLOBAL RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)
FIG 18 GLOBAL AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2023)
FIG 19 WORLDWIDE MAJOR MARKETS FOR AT-HOME DOA TESTING PRODUCTS
FIG 20 NORTH AMERICA AT-HOME DOA TESTING MARKET SNAPSHOT
FIG 21 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2023)
FIG 22 NORTH AMERICA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)
FIG 23 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2023)
FIG 24 NORTH AMERICA AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2023)
FIG 25 EUROPE AT-HOME DOA TESTING MARKET SNAPSHOT
FIG 26 EUROPE AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2023)
FIG 27 EUROPE RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)
FIG 28 EUROPE AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2023)
FIG 29 EUROPE AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2023)
FIG 30 APAC AT-HOME DOA TESTING MARKET SNAPSHOT
FIG 31 APAC AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2023)
FIG 32 APAC RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)
FIG 33 APAC AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2023)
FIG 34 APAC AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2023)
FIG 35 LATAM AT-HOME DOA TESTING MARKET SNAPSHOT
FIG 36 LATAM AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2023)
FIG 37 LATAM RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)
FIG 38 LATAM AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2023)
FIG 39 LATAM AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2023)
FIG 40 MEA AT-HOME DOA TESTING MARKET SNAPSHOT
FIG 41 MEA AT-HOME DOA TESTING MARKET, BY PRODUCT, $M (2013-2023)
FIG 42 MEA RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)
FIG 43 MEA AT-HOME DOA TESTING MARKET, BY SAMPLE, $M (2013-2023)
FIG 44 MEA AT-HOME DOA TESTING MARKET, BY COUNTRY, $M (2013-2023)
FIG 45 PRODUCT BENCHMARKING OF KEY PLAYERS
FIG 46 PSYCHEMEDICS CORPORATION - REVENUE SPLIT BY GEOGRAPHY (2017)
FIG 47 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • UCP Biosciences Inc.
  • Orient New Life Medical Co. Ltd.
  • Express Diagnostics Int'l Inc.
  • Assure Tech (Hangzhou) Co. Ltd.
  • Psychemedics Corporation
  • Confirm BioSciences
  • Phamatech Inc.
  • Home Health (U.K.) Ltd.
  • Quest Products Inc.
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4655427
Adroll
adroll